The alveolar epithelium is comprised of type II and type I cells, which are two morphologically and functionally different epithelial cells. Alveolar type I cells, which are squamous and cover more than 90% of the alveolar surface area, play a major role in gas exchange. 1, 2) On the other hand, alveolar type II cells are cuboidal and outnumber type I cells, although type II cells occupy less than 10% of the surface area even when their apical microvilli are taken into consideration.
Previous studies concerning protein transport across alveolar epithelia have suggested that the transport system most likely to be involved is endocytosis. 9) We also have studied the transport of albumin in alveolar epithelial cells, and found that albumin is internalized into type II and type I cells via a clathrin-mediated endocytic pathway with greater uptake activity in type II cells than in type I cells. 10) These findings indicate that despite the much smaller surface area of type II cells compared to type I cells, type II cells most likely play an important role in the endocytic transport of proteins in alveolar epithelia.
In the case of small proteins (peptides) such as insulin, both paracellular and transcellular routes may be involved in alveolar epithelial transport.
1) Bur et al. 11) reported that in human primary cultured alveolar type I-like epithelial cells, the apparent permeability coefficient of insulin was comparable to that reported for dextran, indicating that a specific, transcellular transport process is not involved. On the other hand, the alveolar epithelial junction was reported to be tighter than other epithelia, 1) suggesting that the contribution of a paracellular route for insulin in alveolar epithelial transport may not be so high. Furthermore, it has been reported that megalin serves as an endocytic receptor for insulin uptake in rat renal proximal tubule cells, 12) and that megalin is also expressed in alveolar epithelial cells. 13) Thus, it is possible that an endocytic pathway is involved in insulin transport in alveolar epithelia. However, little information is available concerning the handling of insulin in alveolar epithelial cells. In addition, it is unclear whether there are any differences or not in the insulin uptake mechanism and activity between type II and type I cells.
In this study, the mechanism and activity of insulin uptake were examined in rat primary cultured alveolar type II epithelial cells and in transdifferentiated type I-like cells.
MATERIALS AND METHODS

Materials
Dulbecco's modified Eagle medium-nutrient mixture F-12 (1 : 1) (DMEM/F-12), penicillin-streptomycin, fungizone, and trypsin (1 : 250, powder) were purchased from Invitrogen (Grand Island, NY, U.S.A.). Fetal bovine serum (FBS) was purchased from Daiichi Pure Chemicals (Tokyo, Japan), and Percoll was obtained from GE Healthcare Bio-Science (Piscataway, NJ, U.S.A.). Deoxyribonuclease I from bovine pancreas, fluorescein isothiocyanate-labeled albumin (FITC-albumin) from bovine serum, FITC-insulin from bovine pancreas, FITC-immunoglobulin G (FITCIgG) from human serum, FITC-transferrin from bovine, FITC-dextran (average molecular weight, 4, 70 kDa), insulin from bovine pancreas, bafilomycin A 1 , phenylarsine oxide, dynasore, and nystatin were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Sodium azide (NaN 3 ), 2,4-dinitro-phenol, and chlorpromazine were purchased from Nacalai Tesque (Kyoto, Japan). 2-Deoxy-D-glucose was purchased from Kanto Chemical (Tokyo, Japan). All other chemicals were of the highest grade commercially available.
Isolation, Purification and Culture of Rat Alveolar Type II Epithelial Cells Experiments with animals were performed in accordance with the "Guide for Animal Experimentation" of Hiroshima University and the Committee of Research Facilities for Laboratory Animal Sciences, Hiroshima University.
Rat alveolar type II epithelial cells were isolated from specific pathogen-free Sprague-Dawley male rats, and purified and cultured as described previously. 10) Briefly, lungs were dispersed enzymatically with 0.25% trypsin and 250 mg/ml deoxyribonuclease I. The cell suspension obtained was purified by discontinuous Percoll density gradient centrifugation. The yield of purified alveolar type II cells per rat was approximately 30ϫ10 6 cells and the cell viability estimated by trypan blue exclusion was more than 90%. The isolated alveolar type II cells were grown at 37°C in culture medium in 5% CO 2 -95% air, and culture medium was replaced every 2 d. Culture medium consisted of DMEM/F-12 supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.25 mg/ml fungizone. For the experiments with type II cells, the cells were seeded at a density of 5ϫ10 6 cells per 35-mm culture dish and used at day 2. Under this culture condition, the cells had a cuboidal shape, and in most of the cells, lamellar bodies, a characteristic feature of alveolar type II cells, were clearly observed inside the cells. For the experiments with type I-like cells, the cells were seeded at a density of 2ϫ10 6 cells per 35-mm culture dish and used at day 6. Under this culture condition, the cells had a flattened, squamous shape, and possessed practically no lamellar bodies as described previously. 10) In addition, we have previously showed that the expression pattern of marker gene mRNAs for type I and type II cells was drastically changed, in accordance with the transdifferentiation from type II cells into type I-like cells.
10)
Uptake of FITC-Labeled Compound Uptake experiments were carried out as described previously 10) at day 2 after seeding 5ϫ10 6 cells per dish or at day 6 after seeding 2ϫ10 6 cells per dish. At day 2 and day 6, the average number of cells per dish was estimated to be around 2ϫ10 6 cells and 3ϫ10 6 cells, respectively. Cells were washed twice and preincubated with phosphate-buffered saline (137 mM NaCl, 3 mM KCl, 8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 0.1 mM CaCl 2 , and 0.5 mM MgCl 2 , pH 7.4) (PBS buffer) supplemented with 5 mM D-glucose (PBS-G buffer) for 10 min at 37°C. Next, PBS-G buffer containing FITC-albumin (20 mg/ml), FITCinsulin (50 mg/ml), FITC-IgG (200 mg/ml), FITC-transferrin (400 mg/ml), or FITC-dextran (4, 70 kDa; 2000 mg/ml) was added and the cells were incubated for 60 min at 37°C. To compare the uptake activities of various substrates estimated using different concentrations, the data were expressed as apparent uptake clearance (ml/h/mg protein or pl/h/cell) for each substrate in Table 1 . For studies on the characteristics of FITC-insulin uptake, cells were incubated with FITC-insulin (20 mg/ml) in PBS-G buffer for 20-60 min at 37°C or 4°C.
To examine the concentration-dependence of insulin uptake, unlabeled insulin was dissolved in 0.1 M HCl, and diluted with potassium free phosphate-buffered saline (137 mM NaCl, 8 mM Na 2 HPO 4 , 2 mM NaH 2 PO 4 , 0.1 mM CaCl 2 , and 0.5 mM MgCl 2 , pH 7.4) (K ϩ free PBS-buffer) supplemented with 5 mM D-glucose (K ϩ free PBS-G buffer). The pH of the insulin solution was then adjusted to 7.4 with 0.1 M NaOH. The cells were washed twice and preincubated with K ϩ free PBS-G buffer and then incubated with the buffer containing FITC-insulin (20 mg/ml) in the presence of various concentrations of unlabeled insulin for 60 min at 37°C or 4°C.
For inhibition studies, cells were preincubated at 37°C or 4°C in the absence or presence of the inhibitor as follows: 10 mM NaN 3 plus 5 mM 2-deoxy-D-glucose or 1 mM 2,4-dinitrophenol in PBS buffer for 10 min, 100 nM bafilomycin A 1 in PBS-G buffer containing 0.1% dimethyl sulfoxide (DMSO) for 30 min, 3 mM phenylarsine oxide, nystatin (32, 54 mM: 30, 50 mg/ml, respectively) or dynasore (30, 60 mM) in PBS-G buffer containing 0.5% DMSO for 10 min, and 28 mM (10 mg/ml) chlorpromazine in PBS-G buffer for 10 min. The same vehicles were used for each control experiment. After preincubation, FITC-insulin (20 mg/ml) with or without the inhibitor was added, and the cells were incubated for 60 min at 37°C or 4°C. Bafilomycin A 1 and phenylarsine oxide were added only during preincubation. The treatment for potassium depletion was conducted as described previously.
10) The control buffer for potassium depletion study consisted of 140 mM NaCl, 10 mM KCl, 20 mM HEPES, 1 mM CaCl 2 , 1 mM MgCl 2 , and 5.6 mM (1 mg/ml) D-glucose (pH 7.4). The control buffer minus KCl was used as potassium depleted buffer.
After incubation, the cells were rinsed three times with ice-cold PBS buffer or K ϩ free PBS buffer (for the study of concentration-dependent insulin uptake) followed by scraping with a rubber policeman. Then, the cells were washed with PBS buffer by centrifugation at 9838 g for 3 min at 4°C twice, and the final pellet was solubilized in 0.1% Triton X-100 in PBS buffer without CaCl 2 and MgCl 2 for 30 min at room temperature and centrifuged at 5600 g for 3 min. The supernatant was used for fluorescence and protein assays. The fluorescence of FITC-labeled compound was measured using a Hitachi fluorescence spectrophotometer F-3000 (Tokyo, Japan) at excitation and emission wavelengths of 500 and 520 nm, respectively. Protein content was determined by the Lowry method with bovine serum albumin as the standard.
Statistical Analysis Data are expressed as the meanϮ S.E. Statistical analysis was performed using the unpaired Student t-test or by one-way ANOVA followed by Dunnett's test for multiple comparisons.
RESULTS
Comparison of Apparent Uptake Clearance of Various
Substrates in Type II and Type I-Like Cells Table 1 shows the apparent uptake (total cell association) clearances of various substrates at 37°C for 60 min in type II and type Ilike cells. The apparent uptake clearance per mg protein values for FITC-albumin and FITC-insulin were much higher than other substrates in both type II and type I-like cells. In particular, the apparent uptake clearance of FITC-albumin in type II cells was markedly high. Those of FITC-dextran (70, 4 kDa) having similar molecular weights to FITC-albumin and FITC-insulin, respectively, were extremely low. Using cell number/mg cell protein estimated by the measurement of DNA content in each type of cell as reported previously (1322ϫ10 4 General Characteristics of Insulin Uptake by Type II and Type I-Like Cells In the following experiments, the amount of FITC-insulin taken up into the cells (uptake) was estimated by subtracting the cell surface binding at 4°C from the total cell association at 37°C. Figure 1A shows the time course of FITC-insulin uptake by type II and type I-like cells. The uptake of FITC-insulin increased with time up to 60 min in both cells and the rate of uptake per mg protein was significantly higher in type II cells than type I-like cells at each time point. On the other hand, FITC-insulin uptake per cell for 60 min was slightly higher in type I-like cells than type II cells (0.089 vs. 0.069 pg/h/cell). Figure 1B shows the concentration-dependence of FITC-insulin uptake for 60 min in type II and type I-like cells. Insulin uptake in both cells showed saturation kinetics. The apparent Michaelis constant (K m ) and maximum uptake rate (V max ) in type II cells were calculated to be 944 mg/ml and 158 mg/h/mg protein, and those in type I-like cells were 2995 mg/ml and 240 mg/h/mg protein, respectively, using Eadie-Hofstee plots.
The effects of metabolic inhibitors on FITC-insulin uptake were examined (Fig. 2) . Treatment of the cells with NaN 3 plus 2-deoxy-D-glucose or 2,4-dinitrophenol completely inhibited FITC-insulin uptake in both type II and type I-like cells. Pretreatment with bafilomycin A 1 , an inhibitor of vacuolar H ϩ -ATPase, significantly inhibited FITC-insulin uptake in type II but not in type I-like cells.
Endocytic Pathways of Insulin Uptake by Type II and Type I-Like Cells The endocytic pathway(s) involved in FITC-insulin uptake by type II and type I-like cells were examined using various inhibitors. Figures 3A and B show the effects of two clathrin-mediated endocytosis inhibitors, phenylarsine oxide and chlorpromazine, on FITC-insulin uptake. FITC-insulin uptake in both cells was not affected by these compounds. We further examined the effect of potassium depletion, which is known to prevent clathrin-coated pit formation and inhibit clathrin-mediated endocytosis (Fig.  3C) . FITC-insulin uptake in both cells was only slightly inhibited by potassium depletion, although a significant difference was observed in type II cells. The effect of dynasore, a dynamin GTPase inhibitor, on FITC-insulin uptake was examined (Fig. 4A) . FITC-insulin uptake by both cells was inhibited by dynasore in a concentration-dependent manner, but the inhibitory effect was much stronger in type II cells than that in type I-like cells. Figure  4B shows the effect of nystatin, a caveolae-mediated endocytosis inhibitor, on FITC-insulin uptake. No inhibitory effect was observed in either type of cell.
DISCUSSION
In order to obtain general information concerning the activity of macromolecule uptake by alveolar epithelial cells, the apparent uptake clearances of albumin, insulin, IgG, transferrin, and the fluid-phase endocytosis marker dextran (4, 70 kDa) were examined and compared between alveolar type II and type I-like epithelial cells. In both type II and type I-like cells, the apparent uptake clearances of FITC-albumin and FITC-insulin were much higher among substrates examined when expressed per mg protein as well as per cell. In addition, the apparent uptake clearance of FITC-dextran was considerably lower than those of FITC-albumin and FITC-insulin, suggesting that the contribution of fluid-phase endocytosis would be very low in the uptake of FITC-albumin and FITC-insulin in alveolar epithelial cells (Table 1) . We previously characterized FITC-albumin uptake in rat primary cultured alveolar type II and type I-like epithelial cells as well as in RLE-6TN cells, an established cell line having some characteristics of type II cells. 10, 14, 15) In this study, the characteristics of FITC-insulin uptake were further examined.
As shown in Fig. 1A , temperature-dependent FITC-insulin uptake increased with time up to 60 min in both cells. At 60 min of incubation, FITC-insulin uptake per cell was slightly higher in type I-like cells than in type II cells (0.089 vs. 0.069 pg/h/cell). Assuming that the number of type II cells in alveolar epithelia is about 1.5-fold of that of type I cells, 1) type II and type I cells were considered to contribute equally to total insulin uptake by alveolar epithelial cells in the lung.
FITC-insulin uptake showed potent energy-dependence in both type II and type I-like cells (Fig. 2) . In contrast, the inhibitory effect of bafilomycin A 1 on FITC-insulin uptake was observed only in type II cells (Fig. 2) . These results may suggest that FITC-insulin is taken up via receptor-mediated endocytosis in type II cells, but not in type I-like cells. Though further information is needed, FITC-insulin may be taken up via adsorptive endocytosis in type I-like cells. Next, we examined the possible endocytic pathway of FITC-insulin in both cells. Clathrin-mediated endocytosis is the best-characterized pathway. 16) However, the clathrin-mediated endocytosis inhibitors phenylarsine oxide and chlorpromazine did not inhibit FITC-insulin uptake in type II and type I-like cells (Figs. 3A, B) . The concentrations of both inhibitors employed were effective at inhibiting the uptake of FITC-albumin in type II and type I-like cells as well as in RLE-6TN cells. 10, 14) In addition, potassium depletion exhibited only a slight decrease in FITC-insulin uptake in both cells (Fig.  3C) . Taken together, these results indicate that clathrin-mediated endocytosis would not be involved in FITC-insulin uptake in type II and type I-like cells, in contrast to albumin uptake in these cells. 10) Endocytic pathways can be classified in terms of their requirements for dynamin. 17) Dynamin is a large GTPase and functions in membrane tubulation and fission of budding vesiculo-tubular structures. 18) Dynasore is an inhibitor of dynamin GTPase activity and blocks dynamin-dependent endocytosis. 18) In this study, dynasore inhibited the uptake of FITC-insulin more potently in type II cells than in type I-like cells (Fig. 4A) . A slight inhibition by dynasore observed in type I-like cells may be a remaining characteristic of type II cells, even after transdifferentiation. The involvement of caveolae-mediated endocytosis was also examined, which is the well-characterized dynamin-dependent but clathrin-independent pathway. 17) Nystatin, a caveolae-mediated endocytosis inhibitor, did not inhibit FITC-insulin uptake in either type of cell (Fig. 4B) , indicating that caveolae-mediated endocytosis is not involved in FITC-insulin uptake in these epithelial cells.
According to the classification of endocytic mechanisms by Mayor and Pagano, 17) several endocytic pathways that are not associated with clathrin and caveolae are emerging. Based on their classification and the present findings, FITCinsulin uptake may be mediated by clathrin-and caveolae-independent, but dynamin-dependent pathway such as the RhoA-regulated pathway in type II cells, and by clathrin-, caveolae-, and dynamin-independent pathways such as the CDC42-and/or ADP-ribosylation factor-6 (ARF6)-regulated pathway in type I-like cells. Further studies are needed to specify the endocytic pathway(s) involved in insulin uptake by alveolar type II and type I cells, but the mechanism underlying insulin uptake in alveolar type II cells would most likely be different from that in type I cells.
In type II cells, the involvement of receptor-mediated endocytosis was suggested. Insulin receptors may possibly be the receptors involved in the FITC-insulin uptake observed in the present study. However, insulin receptors are reported to be expressed in the basolateral membranes of alveolar epithelial cells, 9, 19) where insulin has limited access under the present experimental conditions using culture dishes. Furthermore, the reported K d value of insulin for its receptor in primary rat alveolar epithelial cells is approximately 2.0ϫ10 Ϫ3 mg/ml, 20) which is quite different from the K m value observed in this study. Wang et al. 21) suggested that insulin-like growth factor-I (IGF-I) receptor as well as insulin receptor may mediate insulin transport in endothelial cells in a process involving caveolae. However, no effect of nystatin, a caveolae-mediated endocytosis inhibitor, was observed in the present study. Taken together, it is unlikely that insulin or IGF-I receptors are involved in insulin uptake by alveolar epithelial cells. Another possible receptor for insulin endocytosis is scavenger receptor(s). Scavenger receptors such as SR-AI/II have exceptionally broad specificities and a variety of substrates including anionic proteins can bind to the receptors. 22) In addition, CD36, one of the scavenger receptors, would take up oxidized low density lipoprotein through a pathway that is distinct from clathrin-mediated or caveolin internalization pathways. 23) Further studies are needed in order to identify the receptors involved in insulin endocytosis in alveolar type II epithelial cells.
In conclusion, the contribution of type II cells to insulin uptake in alveolar epithelia was suggested to be nearly equal to that of type I cells. However, the characteristics of insulin uptake in type II cells are distinct from those in type I cells. Dynamin-dependent endocytosis that utilizes neither clathrin nor caveolae is mainly involved in insulin uptake in type II cells, while dynamin-independent endocytosis is mainly involved in insulin uptake in type I cells. These results should provide useful information for understanding the handling of protein and peptide drugs in alveolar epithelial cells.
